Hydrocortisone/Neomycin/Polymyxin B Ophthalmic Dosage
This dosage information may not include all the information needed to use Hydrocortisone/Neomycin/Polymyxin B Ophthalmic safely and effectively. See additional information for Hydrocortisone/Neomycin/Polymyxin B Ophthalmic.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Uveitis
Steroid responsive inflammatory ocular conditions with superficial bacterial infection or risk of infection:
Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 3 to 4 hours. May increase frequency depending on the severity of the condition.
Usual Adult Dose for Bacterial Conjunctivitis
Steroid responsive inflammatory ocular conditions with superficial bacterial infection or risk of infection:
Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 3 to 4 hours. May increase frequency depending on the severity of the condition.
Usual Adult Dose for Keratitis
Steroid responsive inflammatory ocular conditions with superficial bacterial infection or risk of infection:
Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 3 to 4 hours. May increase frequency depending on the severity of the condition.
Usual Adult Dose for Keratoconjunctivitis
Steroid responsive inflammatory ocular conditions with superficial bacterial infection or risk of infection:
Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 3 to 4 hours. May increase frequency depending on the severity of the condition.
Usual Adult Dose for Blepharitis
Steroid responsive inflammatory ocular conditions with superficial bacterial infection or risk of infection:
Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 3 to 4 hours. May increase frequency depending on the severity of the condition.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Patient should be reevaluated if no improvement after 2 days.
Do not prescribe more than 20 mL suspension without further evaluation of the patient's eye(s).
Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).
Dialysis
Data not available
